Sarcoidosis

clock

Anne Llewellyn examines the consequences and underwriting ramifications of this little known disease.

Sarcoidosis is a progressive, inflammatory disease of unknown cause characterised by the formation of granulomas, abnormal nodules of inflamed tissue that can affect any organ, altering its structure and function. It primarily affects young and middle aged adults. Around 20% of those diagnosed with sarcoidosis will experience functional impairment, and the mortality rate is about 5%. A disclosure of sarcoidosis is therefore significant at underwriting stage, but as 80% of sufferers have no impairment the majority of applicants with this condition will be accepted at standard rates or wit...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Protection

Life insurance: Complexity vs cost and the confidence gap

Life insurance: Complexity vs cost and the confidence gap

Complexity and uncertainty create frustration for consumers and operational drag for advisers

Kevin Carr
clock 30 April 2026 • 4 min read
Holloway Friendly and Wiltshire Friendly to merge

Holloway Friendly and Wiltshire Friendly to merge

No job losses anticipated

Jaskeet Briah
clock 20 April 2026 • 2 min read
Protection advisers under 30 report worries about AI use in claims

Protection advisers under 30 report worries about AI use in claims

More concerned about AI used in claims than underwriting

Jaskeet Briah
clock 30 March 2026 • 2 min read